^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    zaptuzumab-MMAE (Oba01)

    i
    Company:
    Yantai Obioadc
    Drug class:
    Microtubule inhibitor, DR5-targeted antibody-drug conjugate
    Related drugs: